[Pathogenetic therapy for caseous pneumonia].
The efficiency of treatment was studied in 79 patients with caseous pneumonia, including 37 patients (a study group) in whom pathogenetic therapy was performed in accordance with the proposed scheme and 42 patients (a control group) used routine treatment regimens. A study of clinical and X-ray picture of caseous pneumonia identified its three variants requiring a differential approach to its treatment, such as an early stage of caseous pneumonia; an infiltrative and necrotic stage; and a caseous and destructive stage. Analysis of the course of the disease showed it necessary to make a timely correction of complex etiotropic and pathogenetic therapy, to determine the optimal time of surgical treatment. The use of a programme for stepwise pathogenetic therapy for caseous pneumonia by taking into account the identified variants decreased the number of fatal outcomes by 2.8 times in the study group of patients as compared with this parameter in the control group.
Chelnokova
O G
OG
Kibrik
B S
BS
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006760:Hospitalization; D006801:Humans; D011014:Pneumonia / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000188:drug therapy / Q000401:mortality / Q000601:surgery
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000975:Antioxidants
Patogeneticheskaia terapiia pri kazeoznoĭ pnevmonii.